Methods using glycosaminoglycans for the treatment of kidney disease

Details for Australian Patent Application No. 2005292202 (hide)

Owner Keryx Biopharmaceuticals, Inc.

Inventors Spero, Michael; Kopp,Jeffrey B.; Weiss, Michael S.

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-A-2005292202

PCT Pub. Number WO2006/039709

Priority 60/615,472 01.10.04 US; 60/622,332 26.10.04 US

Filing date 3 October 2005

Wipo publication date 13 April 2006

International Classifications

A61K 31/70 (2006.01) - Carbohydrates

Event Publications

10 May 2007 PCT application entered the National Phase

  PCT publication WO2006/039709 Priority application(s): WO2006/039709

8 October 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005292227-Methods of treating CD30 positive lymphomas

2005292200-Domain II mutants of anthrax lethal factor